Cargando…
MicroRNAs as theranostic markers in cardiac allograft transplantation: from murine models to clinical practice
Congestive heart failure affects about 23 million people worldwide, and cardiac allograft transplantation remains one of the last options for patients with terminal refractory heart failure. Besides the infectious or oncological complications, the prognosis of patients after heart transplantation is...
Autores principales: | Novák, Jan, Macháčková, Táňa, Krejčí, Jan, Bienertová-Vašků, Julie, Slabý, Ondřej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058726/ https://www.ncbi.nlm.nih.gov/pubmed/33897899 http://dx.doi.org/10.7150/thno.56327 |
Ejemplares similares
-
MicroRNA-206: a Promising Theranostic Marker
por: Novák, Jan, et al.
Publicado: (2014) -
Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing
por: Nováková, Tereza, et al.
Publicado: (2019) -
Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer
por: Slaby, Ondrej, et al.
Publicado: (2012) -
MicroRNAs Involved in the Lipid Metabolism and Their Possible Implications for Atherosclerosis Development and Treatment
por: Novák, Jan, et al.
Publicado: (2014) -
Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
por: Machackova, Tana, et al.
Publicado: (2019)